// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Journalist and writer Andrei Khvostov was the first to express such an idea which was supported by other Estonian writers too.
Sahakyan said that the newly-established company cann't consider Armenia as a potential market for the comping 10 years.
Tis year's Yerevan Half Marathon, slated for October 15, promises to be the best and largest running event in Armenia.
Armenia might be both one of the oldest and one of the youngest nations in the history of beer making, The Smithsonian said in an article.
Partner news